logo

For the Inventor, By the Inventor

West Caldwell, NJ, United States of America

Elliot I Stupak

This inventor holds 14 USPTO granted patents, plus 1 CIPO patent. Top assignee: Schering Corporation. Active years: 1980-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elliot I Stupak. Retrieved from https://idiyas.com/inventor/elliot-i-stupak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 100.0


Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 193(Granted Patents)


Company Filing History:

goldMedal14 out of 1,829 
 
Schering Corporation
 patents

Years Active: 1980-2005

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 6939550 - Stabilized antihistamine syrup (2005-09-06),
2. 6514520 - Stabilized antihistamine syrup (2003-02-04),
3. 6337090 - Orally administrable solid ribavirin dosage forms and process for making them (2002-01-08),
4. 6335032 - Orally administrable solid dosage form (2002-01-01),
5. 6132758 - Stabilized antihistamine syrup (2000-10-17),
6. 6051252 - Orally administrable solid dosage form (2000-04-18),
7. 5916594 - Process of making solid ribavirin dosage forms (1999-06-29),
8. 5914128 - Orally administrable solid dosage form (1999-06-22),
9. 5679356 - Use of GM-CSF as a vaccine adjuvant (1997-10-21),
10. 5162117 - Controlled release flutamide composition (1992-11-10),
11. 4489070 - Betamethasone dipropionate cream (1984-12-18),
12. 4482539 - Betamethasone dipropionate cream (1984-11-13),
13. 4327087 - Stabilized Netilmicin formulations (1982-04-27),
14. 4223022 - Stabilized aminoglycoside antibiotic formulations (1980-09-16),

Title: The Innovative Contributions of Elliot I Stupak

Introduction

Elliot I Stupak is a notable inventor based in West Caldwell, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of stabilized antihistamine syrups. With a total of 14 patents to his name, Stupak's work has had a meaningful impact on the industry.

Latest Patents

Among his latest patents is a stabilized antihistamine syrup. This innovative syrup is designed to be stabilized against the degradation of the active ingredient. The stabilization is achieved through the addition of approximately 0.05 to about 5 mg/mL of an aminopolycarboxylic acid, such as a salt of ethylenediaminetetraacetic acid. This advancement is crucial for maintaining the efficacy of antihistamines in syrup form.

Career Highlights

Elliot I Stupak has spent a significant portion of his career at Schering Corporation, where he has been able to apply his expertise in pharmaceutical innovations. His work has not only contributed to the company's portfolio but has also advanced the field of medicinal chemistry.

Collaborations

Throughout his career, Stupak has collaborated with several talented individuals, including Imtiaz A Chaudry and Stephen M Liebowitz. These collaborations have fostered an environment of innovation and have led to the successful development of various pharmaceutical products.

Conclusion

Elliot I Stupak's contributions to the field of pharmaceuticals, particularly through his patents on stabilized antihistamine syrups, highlight his role as a significant inventor. His work continues to influence the industry and improve the efficacy of medicinal products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…